Cost-effectiveness analysis of treatment for end-stage renal disease;Kostnaoarvirknigreining á meofero vio nýrnabilun á lokastigi

Laeknabladid

Volumn 95, Issue 11, 2009, Pages 747-753

  Ásgeirsdóttir, Tinna Laufey ^a   Ásmundsdóttir, Gyoa ^a   Heimisdóttir, María ^a   Jónsson, Eiríkur ^a   Pálsson, Runólfur ^a  

^a Hagfræoideild ^*

Author keywords

Cost effectiveness; Dialysis; End stage renal disease; Kidney transplantation

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DENMARK; ECONOMICS; HEALTH CARE COST; HUMAN; ICELAND; KIDNEY TRANSPLANTATION; LIVING DONOR; MORTALITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; STATISTICAL MODEL; TREATMENT OUTCOME;

COST-BENEFIT ANALYSIS; DENMARK; HEALTH CARE COSTS; HUMANS; ICELAND; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MODELS, ECONOMIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 73349129089     PISSN: 00237213     EISSN: 16704959     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Oniscu GC, Brown H, Forsythe JL. Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol 2005; 16: 1859-1865
2. Simmons RG, Abress L. Quality-of-life issues for end-stage renal disease patients. Am J Kidney Dis 1990; 15: 201-208
3. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242
4. Cameron JI, Whiteside C, Katz J, Devins GM. Differences in quality of life across renal replacement therapies: a metaanalytic comparison. Am J Kidney Dis 2000; 35: 629-637
5. Ásmundsson P, Pálsson R. Meofero vio lokastigsný rnabilun á Íslandi 1968-1997. Læknablaoio 1999; 85: 9-24.
6. ERA-EDTA Registry: ERA-EDTA Registry 2006 Annual Report. Academic Medical Center, Department of Medical Informatics, Amsterdam, Holland 2008.
7. U.S. Renal Data System, USRDS 2007 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda MD 2007.
8. Manns BJ, Taub KJ, Donaldson C. Economic evaluation and end-stage renal disease: from basics to bedside. Am J Kidney Dis 2000; 36: 12-28.
9. Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ 2006; 332: 563-564
10. Eggers P. Comparison of treatment costs between dialysis and transplantation. Semin Nephrol 1992; 12: 284-289
11. Karlberg I, Nyberg G. Cost-effectiveness studies of renal transplantation. Int J Technol Assess Health Care 1995; 11:611-622
12. Drummond MF, ÓBrien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. Oxford Medical Publications, New York 1997.
13. Ásgeirsdóttir TL. Holdafar - hagfræoileg greining. Lýoheilsustöo, Reykjavík 2007.
14. Íbúoalánasjóour 2007. ils.is
15. Gold MR, Siegel JE, Russell LB, Weinstein MC editors. Cost-Effectiveness in Health and Medicine. Oxford University Press, New York 1996.
16. Guonason, Oddsson K, Jóhannsson J, Ásgeirsdóttir TL. Bólusetning gegn leghálskrabbameinsvaldandi HPV (Human Papilloma Veirum): Kostnaoarvirknigreining á Íslandi. 2008 landlaeknir.is
17. hagstofa.is
18. Port FK, Merion RM, Roys EC, Wolfe RA. Trends in organ donation and transplantation in the United States, 1997-2006. Am J Transplant 2008; 8: 911-921
19. de Wit GA, Ramsteijn PG, de Charro FT. Economic evaluation of end stage renal disease treatment. Health Policy 1998; 44: 215-232
20. Kontodimopoulos N, Niakas D. An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy. Health Policy 2008; 86: 85-96.
21. Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Economics 2004; 13: 437-452
22. Matza L, Paramore C, Prasad M. A review of the economic burden of ADHD. Cost Eff Resour Alloc 2005; 3: 1478-1487
23. sedlabanki.is.
24. McDonald SP, Russ GR. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001. Nephrol Dial Transplant 2002; 17: 2212-2219
25. Rabbat CG, Thorpe KE, Russell JD, Churchill DN. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol 2000; 11: 917-922
26. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730